Heat inactivated convalescent plasma Uses, Dosage, Side Effects and more
COVID-19 convalescent plasma is currently being acquired from recovered COVID-19 patients and used as prophylaxis for the virus. This therapeutic concept was applied to the development of Heat inactivated convalescent plasma, which heat inactivates the plasma, and packages it into a once-daily pill form. Immunitor Inc., the sponsor, is currently testing this oral vaccine for immunogenicity in 20 healthy volunteers in a Phase 1 clinical trial (NCT04380532).
| Trade Name | Heat inactivated convalescent plasma |
| Generic | V-SARS |
| V-SARS Other Names | Heat inactivated convalescent plasma |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
